🇺🇸 Clopidogrel and aspirin dual-antiplatelet therapy in United States

Clopidogrel and aspirin dual-antiplatelet therapy (Clopidogrel and aspirin dual-antiplatelet therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Clopidogrel and aspirin dual-antiplatelet therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Clopidogrel and aspirin dual-antiplatelet therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Clopidogrel and aspirin dual-antiplatelet therapy in United States?

Harbin Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.